Wall Street brokerages predict that Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) will report earnings of ($0.14) per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Voyager Therapeutics’ earnings. The highest EPS estimate is $0.64 and the lowest is ($0.56). Voyager Therapeutics reported earnings of ($0.58) per share […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) COO Robin Swartz sold 1,527 shares of the business’s stock in a transaction on Monday, April 4th. The shares were sold at an average price of $8.25, for a total value of $12,597.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) has received a consensus rating of “Buy” from the eight ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target […]
Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results License option agreement with Novartis for target-specific access. | March 8, 2022